Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0116 | 0.168 | 0.2592 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0666 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0222 | 0.1228 |
Schistosoma mansoni | cpg binding protein | 0.0032 | 0.0407 | 0.0512 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0666 | 1 | 1 |
Echinococcus multilocularis | smad | 0.0008 | 0.0057 | 0.0025 |
Schistosoma mansoni | cpg binding protein | 0.0032 | 0.0407 | 0.0512 |
Brugia malayi | MH2 domain containing protein | 0.0124 | 0.1807 | 1 |
Loa Loa (eye worm) | doublecortin family protein | 0.0019 | 0.0222 | 0.1228 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0425 | 0.6361 | 1 |
Loa Loa (eye worm) | histone methyltransferase | 0.0009 | 0.0069 | 0.0382 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0057 | 0.0316 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0008 | 0.0057 | 0.0025 |
Echinococcus granulosus | RUN | 0.0019 | 0.0222 | 0.0286 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0225 | 1 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0009 | 0.0067 | 0.0372 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.0225 | 0.5 |
Echinococcus granulosus | microsomal glutathione S transferase 3 | 0.011 | 0.159 | 0.2451 |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.0225 | 1 |
Onchocerca volvulus | 0.003 | 0.0381 | 1 | |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0225 | 0.0003 |
Schistosoma mansoni | polycystin 1-related | 0.0019 | 0.0222 | 0.0253 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0225 | 0.5 |
Echinococcus granulosus | Smad4 | 0.0008 | 0.0057 | 0.0025 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0124 | 0.1807 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0666 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0057 | 0.0316 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0225 | 0.0257 |
Schistosoma mansoni | membrane associated proteins in eicosanoid and glutathione metabolism family member | 0.0479 | 0.7176 | 1 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0019 | 0.0222 | 0.0286 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0666 | 1 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0069 | 0.0044 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0069 | 0.0044 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.0225 | 0.5 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.0225 | 0.5 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0019 | 0.0222 | 0.0286 |
Schistosoma mansoni | loxhd1 | 0.0019 | 0.0222 | 0.0253 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0666 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0222 | 0.1228 |
Echinococcus granulosus | smad | 0.0008 | 0.0057 | 0.0025 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0019 | 0.0222 | 0.0286 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0008 | 0.0057 | 0.0316 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.0381 | 0.0476 |
Schistosoma mansoni | microsomal glutathione s-transferase | 0.011 | 0.159 | 0.217 |
Schistosoma mansoni | rab6-interacting | 0.0019 | 0.0222 | 0.0253 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0019 | 0.0222 | 0.0286 |
Schistosoma mansoni | smad | 0.0008 | 0.0057 | 0.0022 |
Schistosoma mansoni | lipoxygenase | 0.0116 | 0.168 | 0.2296 |
Echinococcus granulosus | cpg binding protein | 0.0032 | 0.0407 | 0.0578 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.002 | 0.0225 | 0.5 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0057 | 0.0316 |
Brugia malayi | Smad1 | 0.0008 | 0.0057 | 0.0316 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0057 | 0.0022 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0008 | 0.0057 | 0.0022 |
Schistosoma mansoni | rab6-interacting | 0.0019 | 0.0222 | 0.0253 |
Loa Loa (eye worm) | Smad1 | 0.0008 | 0.0057 | 0.0316 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0057 | 0.0785 | 0.4101 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0008 | 0.0057 | 0.0025 |
Schistosoma mansoni | lipoxygenase | 0.0081 | 0.1153 | 0.1558 |
Echinococcus multilocularis | microsomal glutathione S transferase 3 | 0.011 | 0.159 | 0.2451 |
Brugia malayi | CXXC zinc finger family protein | 0.003 | 0.0381 | 0.2108 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0222 | 0.1228 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0222 | 0.1228 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.0225 | 0.029 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.0225 | 0.029 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.0225 | 0.0003 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0008 | 0.0057 | 0.0025 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0666 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0222 | 0.0253 |
Brugia malayi | Doublecortin family protein | 0.0019 | 0.0222 | 0.1228 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0116 | 0.168 | 0.2592 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.003 | 0.0381 | 0.2108 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0019 | 0.0222 | 0.0286 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.0225 | 0.1245 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0666 | 1 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.0225 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0057 | 0.0316 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0063 | 0.0887 | 0.1185 |
Echinococcus granulosus | dnaJ subfamily B | 0.0425 | 0.6361 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.0225 | 0.0257 |
Echinococcus multilocularis | RUN | 0.0019 | 0.0222 | 0.0286 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0057 | 0.0022 |
Echinococcus multilocularis | cpg binding protein | 0.0032 | 0.0407 | 0.0578 |
Toxoplasma gondii | MAPEG family protein | 0.011 | 0.159 | 1 |
Echinococcus multilocularis | Smad4 | 0.0008 | 0.0057 | 0.0025 |
Schistosoma mansoni | hypothetical protein | 0.0425 | 0.6361 | 0.8857 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0019 | 0.0222 | 0.0286 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0057 | 0.0022 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0124 | 0.1807 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.0225 | 0.1245 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0008 | 0.0057 | 0.0316 |
Schistosoma mansoni | Smad4 | 0.0008 | 0.0057 | 0.0022 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0087 | 0.1237 | 1 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0008 | 0.0057 | 0.0025 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.